NEWS

WIRES

OTHER

Rockefeller and Company Releases 'Investment Opportunities in Healthcare Reform' White Paper

Authored by Dr. David K. Song, M.D., Ph.D., an equity analyst covering the healthcare sector within the asset management group at Rockefeller and Company, the central thrust of the white paper is that the intense US healthcare reform debate has temporarily pushed down valuations of healthcare stocks. That, coupled with strong global demographic trends, has created a promising opportunity for long-term investors in the healthcare sector.

According to the white paper, as emerging societies continue to become wealthier, they will likely spend more money on medical care as their populations seek to live longer and healthier lives. Moreover, as the storm cloud of healthcare-reform uncertainty hovers over Washington, short-sighted investors are missing an opportunity to participate in a sector that is expected to grow in excess of global GDP for the foreseeable future.

Other key highlights of Rockefeller and Company's healthcare white paper include:

    --  Healthcare stock valuations are trading at or near multi-year lows,
        coinciding with the uncertainty of healthcare reform; healthcare stocks
        are trading currently at a 44% discount to the general market, a far
        larger discount than even during the Clinton administration's effort to
        reform healthcare.

    --  Balancing all the political considerations, the most likely legislation
        to be enacted will essentially insure well more than 30 million
        currently uninsured individuals, without doing much in the way of
        restraining costs.

    --  Investors also have some potential upside in the sector even if no
        healthcare reform bill is signed.

    --  Regardless of the outcome of healthcare reform, compelling secular
        trends in the healthcare sector remain fully intact:

    1. Rising prosperity in emerging markets should drive the demand for
       healthcare.
    2. Even though governments in developed countries are concerned with rising
       healthcare costs, the pace of healthcare spending in developed markets is
       expected to continue above GDP growth, given aging populations and the
       increasing prevalence of chronic conditions such as obesity, diabetes and
       neurodegenerative disorders.
    3. Continued technological advances in the life sciences are key drivers for
       the sector.  Importantly, continued incentives for medical technology in
       developed countries and strengthening intellectual property laws in
       emerging markets only help to fuel already robust innovation.

Prior to joining Rockefeller and Company, Dr. Song worked in healthcare investment research at other financial firms. Dr. Song graduated Magna Cum Laude from Yale University with a BS in economics and molecular physics and biochemistry, and received a medical degree from the University of Pennsylvania as well as a Ph.D. from the Wharton School of Business.

To request a complimentary copy of Rockefeller and Company's "The Investment Opportunities in Healthcare Reform" white paper, please contact your client advisor at Rockefeller and Company or email Elena Cooper at ecooper@rockco.com.

To schedule an interview with Dr. Song to discuss the white paper, please contact Joe Kuo (212-521-4863 or joe-kuo@kekst.com) or Michael Herley (212-521-4897 or michael-herley@kekst.com) of Kekst and Company Incorporated.

Rockefeller & Co., Inc.

Headquartered in New York and with offices in Boston, Washington D.C. and Wilmington, Delaware, Rockefeller and Company is a leading global wealth management firm that provides comprehensive wealth and investment management services to a diversified client base of high net worth individuals, families, trusts, foundations and endowments. Independent and privately-owned, the firm has three wholly owned subsidiaries: Rockefeller Trust Company, N.A., a national limited purpose trust company, The Rockefeller Trust Company (Delaware), a Delaware limited purpose trust company, and Rockit Solutions, LLC, a leading provider of wealth data aggregation and reporting solutions for single-family and multi-family offices, high net worth individuals and financial institutions. Rockefeller and Company was incorporated in 1979 and registered with the Securities and Exchange Commission in 1980 as an investment adviser. As of September 30, 2009, the firm and its subsidiaries had approximately $24 billion in assets under administration.

SOURCE Rockefeller & Co., Inc.